Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition
OBJECTIVE: To investigate features of Guillain-Barré syndrome (GBS) following SARS-CoV-2 vaccines an...
Vaccination against viruses has rarely been associated with Guillain-Barré syndrome (GBS). An associ...
COVID-19 is a global pandemic which has varied array of symptoms. A neurotropic presentation has als...
Several reports and studies are being conducted to this day based on the safety profile of COVID-19 ...
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. T...
Several formulations of vaccines against novel coronavirus have been launched. Thereby, increasing t...
Although SARS-CoV-2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthe...
Although SARS-CoV-2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthe...
Key Clinical Message Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occu...
Guillain-Barre syndrome (GBS) is a rare immune mediated clinical disorder of the peripheral nerves. ...
The Guillain Barre Syndrome (GBS) is an acute immune-mediated progressive polyneuropathy having an a...
Guillain-Barré-Syndrome (GBS) is one of the reported neurological manifestations linked to a severe ...
Background: COVID-19 related Guillain-Barré syndrome has a broad spectrum of presentation. In most r...
The spectrum of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 infection (SARS-...
The spectrum of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 infection (SARS-...
OBJECTIVE: To investigate features of Guillain-Barré syndrome (GBS) following SARS-CoV-2 vaccines an...
Vaccination against viruses has rarely been associated with Guillain-Barré syndrome (GBS). An associ...
COVID-19 is a global pandemic which has varied array of symptoms. A neurotropic presentation has als...
Several reports and studies are being conducted to this day based on the safety profile of COVID-19 ...
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. T...
Several formulations of vaccines against novel coronavirus have been launched. Thereby, increasing t...
Although SARS-CoV-2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthe...
Although SARS-CoV-2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthe...
Key Clinical Message Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occu...
Guillain-Barre syndrome (GBS) is a rare immune mediated clinical disorder of the peripheral nerves. ...
The Guillain Barre Syndrome (GBS) is an acute immune-mediated progressive polyneuropathy having an a...
Guillain-Barré-Syndrome (GBS) is one of the reported neurological manifestations linked to a severe ...
Background: COVID-19 related Guillain-Barré syndrome has a broad spectrum of presentation. In most r...
The spectrum of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 infection (SARS-...
The spectrum of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 infection (SARS-...
OBJECTIVE: To investigate features of Guillain-Barré syndrome (GBS) following SARS-CoV-2 vaccines an...
Vaccination against viruses has rarely been associated with Guillain-Barré syndrome (GBS). An associ...
COVID-19 is a global pandemic which has varied array of symptoms. A neurotropic presentation has als...